Items where authors include "Baraliakos, X."

Article

Zabotti, A. orcid.org/0000-0002-0573-464X, Fagni, F. orcid.org/0000-0002-6122-0774, Gossec, L. orcid.org/0000-0002-4528-310X et al. (15 more authors) (2024) Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD Open, 10 (2). e004314. ISSN 2056-5933

Bosch, P., Carubbi, F., Scirè, C.A. et al. (4 more authors) (2021) Value of imaging to guide interventional procedures in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open, 7 (3). e001864. ISSN 2056-5933

Sepriano, A., Regel, A., van der Heijde, D. et al. (6 more authors) (2017) Efficacy and safety of biological and targeted-synthetic DMARDs : a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. RMD Open, 3 (1). e000396.

Regel, A., Sepriano, A., Baraliakos, X. et al. (6 more authors) (2017) Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. RMD Open, 3 (1). e000397. ISSN 2056-5933

Conference or Workshop Item

Torgutalp, M., Azevedo, V., Baraliakos, X. et al. (39 more authors) (2024) Characteristics of Patients with Psoriatic Arthritis Presenting with Axial Involvement: Results of a Prospective International Multicenter Study (AXIS). In: ACR Convergence 2024, 14-19 Nov 2024, Washington, D. C..

Baraliakos, X., Bird, P., Deodhar, A. et al. (15 more authors) (2024) Associations Between Clinical Characteristics and Screening MRI Findings: Exploratory Analysis of the Ongoing Phase 4, Multicenter, Randomized, Controlled STAR Study of Biologic-Naïve Patients with PsA with MRI-Confirmed Axial Involvement. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

Proceedings Paper

Zabotti, A., De Marco, G. orcid.org/0000-0003-2406-161X, Gossec, L. et al. (26 more authors) (2023) OP0062 EULAR points to consider for the definition of clinical and imaging features suspicious for progression to psoriatic arthritis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 42-43.

Gladman, D.D., Mease, P.J., Bird, P. et al. (13 more authors) (2022) AB0894 Efficacy and Safety of Guselkumab in Biologic-Naïve Patients With Active Axial Psoriatic Arthritis: Study Design of a Phase 4, Randomized, Double-Blind, Placebo-Controlled Trial. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 1574-1575.

Mease, P.J., Helliwell, P., Gladman, D.D. et al. (10 more authors) (2022) POS1037 Effect Of Guselkumab, A Selective Il-23p19 Inhibitor, On Axial-Related Endpoints In Patients With Active Psa: Results From A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Through 2 Years. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 832-833.